TrialJournal of clinical immunology2010

Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency.

John B Hagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.